StockData
Gelteq Ltd logo

Gelteq Ltd (GELS) stock

GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 16, 2026Score 0/30
$0.28+0.01 (+3.93%)

Close on Nov 19, 2026Market cap $3.01MP/E –Yield –

Gelteq net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2024 it was -A$3.55M.

Annual net income

PeriodPeriod endValueChange
FY2024Jun 30, 2024-A$3.55M–
FY2023Jun 30, 2023-A$3.51M–

More Gelteq figures

See a number that looks wrong?